Story perspectives
Trump Adds Affordable Diabetes and COPD Drugs to TrumpRx
3/21/2026
1 of 1
Story summary
- U.S. President Donald Trump announced three drugs were added to TrumpRx self-pay platform to lower costs.
- The drugs are Jentadueto and Jentadueto XR for Type 2 diabetes, and Striverdi Respimat for COPD.
- Jentadueto is priced around $55 versus $525 at retail.
- A poll found that one in three U.S. adults have made sacrifices to afford healthcare.
- TrumpRx is intended as a cash-pay tool, not a comprehensive solution for drug pricing.
